Overview of preparedness and response to COVID-19 in Ghana.


Journal

Ghana medical journal
ISSN: 2616-163X
Titre abrégé: Ghana Med J
Pays: Ghana
ID NLM: 0073210

Informations de publication

Date de publication:
Jun 2021
Historique:
entrez: 2 3 2022
pubmed: 3 3 2022
medline: 4 3 2022
Statut: ppublish

Résumé

The Coronavirus disease 2019 (COVID-19) outbreak in Ghana is part of an ongoing pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The first two cases of COVID-19 were confirmed in Ghana on 12th March 2020. COVID-19 was consequently declared a Public Health Emergency of National Concern, triggering several response actions, including enhanced surveillance, case detection, case management and contact tracing, closure of borders, suspension of international flights, ban on social gatherings and closure of schools. Preparedness and response plans were activated for implementation at the national, regional, district and community levels. Ghana's Strategic approaches were to limit and stop the importation of cases; detect and contain cases early; expand infrastructure, logistics and capacity to provide quality healthcare for the sick; minimise disruption to social and economic life and increase the domestic capacity of all sectors to deal with existing and future shocks. The health sector strategic frame focused on testing, treatment, and tracking. As of 31st December 2020, a total of 535,168 cases, including 335 deaths (CFR: 0.61%), have been confirmed with 53,928 recoveries and 905 active cases. All the regions have reported cases, with Greater Accra reporting the highest number. The response actions in Ghana have seen high-level political commitment, appropriate and timely decisions, and a careful balance of public health interventions with economic and socio-cultural dynamics. Efforts are ongoing to intensify non-pharmaceutical interventions, sustain the gains made so far and introduce COVID-19 vaccines to reduce the public health burden of the disease in Ghana. None declared.

Identifiants

pubmed: 35233113
doi: 10.4314/gmj.v55i2s.6
pii: jGMJ.v55.i2s.pg38
pmc: PMC8853692
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-47

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/J01477X/1
Pays : United Kingdom

Informations de copyright

Copyright © The Author(s).

Déclaration de conflit d'intérêts

Conflict of interest: None declared

Références

JAMA. 2020 Apr 21;323(15):1499-1500
pubmed: 32159735
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
BMC Med. 2020 Feb 28;18(1):57
pubmed: 32106852
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814
Rev Med Virol. 2021 May;31(3):e2179
pubmed: 33035373
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):407-412
pubmed: 32335367
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Cell Biosci. 2020 Mar 16;10:40
pubmed: 32190290
AJR Am J Roentgenol. 2020 Jul;215(1):87-93
pubmed: 32174129

Auteurs

Badu Sarkodie (B)

Ghana Health Service - Public Health Division, P. M. B. Ministries, Accra, Ghana.

Franklin Asiedu-Bekoe (F)

Ghana Health Service - Disease Surveillance Department, KB 490 Korle-Bu, Accra, Ghana.

Dennis O Laryea (DO)

Ghana Health Service - Public Health Division, P. M. B. Ministries, Accra, Ghana.

William K Ampofo (WK)

Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana. Legon, Accra, Ghana.

Richard O Phillips (RO)

Kwame Nkrumah University of Science and Technology - Kumasi Centre for Collaborative Research, Kumasi, Ghana.

Ali Samba (A)

University of Ghana School of Medicine and Dentistry - Department of Obstetrics and Gynaecology, Accra, Ghana.

Aboagye Da Costa (A)

Ghana Health Service - Public Health Division, P. M. B. Ministries, Accra, Ghana.
Ghana Health Service - Disease Surveillance Department, KB 490 Korle-Bu, Accra, Ghana.
Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana. Legon, Accra, Ghana.
Kwame Nkrumah University of Science and Technology - Kumasi Centre for Collaborative Research, Kumasi, Ghana.
University of Ghana School of Medicine and Dentistry - Department of Obstetrics and Gynaecology, Accra, Ghana.
Presidential Taskforce on COVID-19, Office of the President, Jubilee House, Accra, Ghana.
Ministry of Health, P.O.Box M44 Accra, Ghana.
World Health Organization, Accra, Ghana.
Ghana Health Service Headquarters, Accra, Ghana.

Anthony Nsiah-Asare (A)

Presidential Taskforce on COVID-19, Office of the President, Jubilee House, Accra, Ghana.

Anarfi Asamoah-Baah (A)

Presidential Taskforce on COVID-19, Office of the President, Jubilee House, Accra, Ghana.

Emmanuel Odame (E)

Ministry of Health, P.O.Box M44 Accra, Ghana.

Sally-Anne Ohene (SA)

World Health Organization, Accra, Ghana.

Yaw A Amoako (YA)

Kwame Nkrumah University of Science and Technology - Kumasi Centre for Collaborative Research, Kumasi, Ghana.

Patrick Kuma-Aboagye (P)

Ghana Health Service Headquarters, Accra, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH